Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control.
about
Pharmacotherapy in the management of asthma in the elderly: a review of clinical studiesClinical asthma phenotypes in the real world: opportunities and challengesAdd-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhalerSmall airways dysfunction in asthma: evaluation and management to improve asthma control.Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life?Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial.Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibitionFailure in asthma control: reasons and consequences.Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/dayEmerging interleukin receptor antagonists for the treatment of asthma.Budesonide + formoterol fumarate dihydrate for the treatment of asthma.Effect of Pregnancy on Quantitative Medication Use and Relation to Exacerbations in Asthma.Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.Effect of inhaled corticosteroids on salival composition: a cross-sectional study in patients with bronchial asthma.Stepping Up Asthma Therapy in the "Real World".Xerostomia relates to the degree of asthma control.
P2860
Q26769046-35B65468-8C78-4BC1-BCC9-94E258D8C4BFQ26775236-7F4CA303-0009-4F59-900B-B3C5163D55C8Q28596628-6D499783-26BF-47E5-826B-549120EC7121Q34167882-8A4F2B31-2115-486C-9704-1599E1149829Q34170583-B739C77F-8199-4988-AE1A-38ACB6F02040Q34637901-9E995FF1-7701-43CD-8A8C-1CF186C8F7CBQ36027085-85C347B2-5057-4E88-91F4-92324F57D647Q36200568-CBAD2B5E-AFFC-411D-9626-179CA4DF8A15Q36619748-E7795021-E3BF-4E3D-B581-2544FBDAFAFFQ37437089-788743B5-A426-43A9-A97E-A68E93EE1B37Q37658668-52036453-FA1C-42D8-9270-393136BFF691Q37698922-A4A1D859-9663-4469-9DDA-411B86BFA79AQ38638355-3855900E-845B-47C5-A61D-4B1517853582Q38806274-1574B0A1-BB1C-4876-A29C-8F0CA436657FQ41229636-47802601-DF95-4A89-9A6A-2518DCFAF72CQ41256329-87091F28-F66E-4D8A-8C8A-6DC982690037Q45347741-DF4C2C7D-9EF1-40A6-9896-1AF7D8AAC398Q47964882-05F4E77B-59CA-4C2A-9E30-952BDD94B1E5Q48067214-0041646F-819B-4A28-8BA3-9D8471CFCBB6
P2860
Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Increasing doses of inhaled co ...... s in achieving asthma control.
@en
Increasing doses of inhaled co ...... s in achieving asthma control.
@nl
type
label
Increasing doses of inhaled co ...... s in achieving asthma control.
@en
Increasing doses of inhaled co ...... s in achieving asthma control.
@nl
prefLabel
Increasing doses of inhaled co ...... s in achieving asthma control.
@en
Increasing doses of inhaled co ...... s in achieving asthma control.
@nl
P2093
P356
P1433
P1476
Increasing doses of inhaled co ...... s in achieving asthma control.
@en
P2093
Anders Kallen
Ian P Naya
Peter J Barnes
P304
P356
10.1378/CHEST.08-1018
P407
P577
2008-08-08T00:00:00Z